| Dr Valerie Michelle Oram, MD | |
|
317 E 34th St Fl 5, New York, NY 10016-4911 | |
| (212) 981-7258 | |
| (212) 209-3218 |
| Full Name | Dr Valerie Michelle Oram |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 20 Years |
| Location | 317 E 34th St Fl 5, New York, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063654994 | NPI | - | NPPES |
| A400015635 | Other | NY | MEDICARE PTAN |
| A400040610 | Other | NY | MEDICARE PTAN |
| 00506318 | Other | NY | MEDICAID GROUP NUMBER |
| 03135802 | Medicaid | NY | |
| P00788628 | Other | NY | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 240824 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai St Luke's Roosevelt Hospital | New york, NY | Hospital |
| Mount Sinai Beth Israel | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Icahn School Of Medicine At Mount Sinai | 2264691070 | 2339 |
News Archive
In a special supplement to Pediatrics, edited and sponsored by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), physicians will have access in one place to the reviews and analyses of current research on biological, behavioral, and environmental changes during childhood and adolescence that foster the initiation, maintenance, and acceleration of illegal use of alcohol by underage youth.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
Biologists at New York University have uncovered one way that biological clocks control neuronal activity - a discovery that sheds new light on sleep-wake cycles and offers potential new directions for research into therapies to address sleep disorders and jetlag.
Legislation to overhaul the American health system lacks an overarching plan to curb the rising costs of medicine, according to Atul Gawande, the influential surgeon and writer, in an essay for the Dec. 14 issue of The New Yorker. "Does the bill end medicine's destructive piecemeal payment system? Does it replace paying for quantity with paying for quality? Does it institute nationwide structural changes that curb costs and raise quality? It does not," Gawande writes. "Instead, what it offers is . . . pilot programs."
› Verified 4 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568841930 PECOS PAC ID: 2264691070 Enrollment ID: O20151112000217 |
News Archive
In a special supplement to Pediatrics, edited and sponsored by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), physicians will have access in one place to the reviews and analyses of current research on biological, behavioral, and environmental changes during childhood and adolescence that foster the initiation, maintenance, and acceleration of illegal use of alcohol by underage youth.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
Biologists at New York University have uncovered one way that biological clocks control neuronal activity - a discovery that sheds new light on sleep-wake cycles and offers potential new directions for research into therapies to address sleep disorders and jetlag.
Legislation to overhaul the American health system lacks an overarching plan to curb the rising costs of medicine, according to Atul Gawande, the influential surgeon and writer, in an essay for the Dec. 14 issue of The New Yorker. "Does the bill end medicine's destructive piecemeal payment system? Does it replace paying for quantity with paying for quality? Does it institute nationwide structural changes that curb costs and raise quality? It does not," Gawande writes. "Instead, what it offers is . . . pilot programs."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Valerie Michelle Oram, MD 317 E 34th St Fl 5, New York, NY 10016-4911 Ph: (212) 981-7258 | Dr Valerie Michelle Oram, MD 317 E 34th St Fl 5, New York, NY 10016-4911 Ph: (212) 981-7258 |
News Archive
In a special supplement to Pediatrics, edited and sponsored by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), physicians will have access in one place to the reviews and analyses of current research on biological, behavioral, and environmental changes during childhood and adolescence that foster the initiation, maintenance, and acceleration of illegal use of alcohol by underage youth.
Genzyme Corporation (Nasdaq: GENZ) announced today that its supplemental New Drug Application for Clolar® (clofarabine) will be discussed Tuesday, September 1 at a public meeting of the FDA's Oncologic Drugs Advisory Committee in Silver Spring, Maryland. The panel is expected to consider the clinical trial results Genzyme submitted to support the approval and labeling of Clolar to treat older adult patients with acute myeloid leukemia (AML), the most common type of acute leukemia in adults.
Biologists at New York University have uncovered one way that biological clocks control neuronal activity - a discovery that sheds new light on sleep-wake cycles and offers potential new directions for research into therapies to address sleep disorders and jetlag.
Legislation to overhaul the American health system lacks an overarching plan to curb the rising costs of medicine, according to Atul Gawande, the influential surgeon and writer, in an essay for the Dec. 14 issue of The New Yorker. "Does the bill end medicine's destructive piecemeal payment system? Does it replace paying for quantity with paying for quality? Does it institute nationwide structural changes that curb costs and raise quality? It does not," Gawande writes. "Instead, what it offers is . . . pilot programs."
› Verified 4 days ago
Dr. Ravishankar Ramaswamy, MD, MS Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1440 Madison Avenue, New York, NY 10029 Phone: 212-659-8552 Fax: 212-860-9737 | |
Dr. Pietro Alessandro Ambrogio Canetta, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, Ph4-124, New York, NY 10032 Phone: 212-305-5020 Fax: 212-305-6692 | |
Dr. Rakhshan Mahmood Chida, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 327 E 17th St, New York, NY 10003 Phone: 212-420-5690 | |
Charles D Resor, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, New York, NY 10032 Phone: 212-305-2913 | |
Dr. Jacqueline Yuey Lonier, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1150 Saint Nicholas Ave, New York, NY 10032 Phone: 212-851-5494 | |
Dr. Sharon Uralil, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 550 1st Ave, New York, NY 10016 Phone: 212-263-3293 | |
Diana Kantor, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 775 9th Ave, New York, NY 10019 Phone: 212-586-1550 |